Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Synergy Names Gary Sender CFO | Contract Pharma
Promotions & Moves

Synergy Names Gary Sender CFO

Most recently served as Shire’s SVP of finance

Synergy Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, has appointed Gary Sender as executive vice president and chief financial officer. Mr. Sender will be responsible for leading Synergy’s financial strategy and operations, supporting all functions of the organization.

“Gary is a strong leader whose broad experience in small and larger specialty pharmaceutical organizations uniquely qualifies him to lead and build our financial operations as we enter a transformative period in our history,” said Gary Jacob, chairman and chief executive officer, Synergy. “Having previously managed financial planning and analysis and strategic growth initiatives of Shire’s global commercial businesses, Gary has a thorough understanding of the exciting opportunities from which Synergy is poised to benefit. I’m confident he can add significant value as we prepare to successfully enter a growing and dynamic GI market.”

Mr. Sender has over 25 years of financial leadership experience in the pharmaceutical and biopharmaceutical industries, most recently at Shire plc. From 2009-2015 he served as senior vice president, finance supporting its specialty pharmaceuticals business and subsequently its global commercial businesses.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters